Performance & Muscle
Growth hormone secretagogues and anabolic pathways (Ipamorelin, Tesamorelin, CJC-1295).
Overview
Performance peptide research centers on the growth-hormone (GH) and IGF-1 axis: GHRH analogs (sermorelin, CJC-1295, tesamorelin), ghrelin-mimetic GH secretagogues (GHRP-2, GHRP-6, hexarelin, ipamorelin), and downstream GH-fragment and IGF-1 derivatives. The unifying mechanism is amplification of endogenous pulsatile GH release rather than exogenous recombinant GH administration. Adjacent agents include follistatin (myostatin antagonism for muscle hypertrophy), AICAR (AMPK-driven endurance phenotype shift), and IGF-1 LR3 (long-acting IGF-1 analog). Every compound in this category is either FDA-approved for a narrow indication (tesamorelin for HIV lipodystrophy) or investigational/research-use-only.
Biological Pathways
5-Amino-1MQ
Popular Name: 5-Amino-1-methylquinolinium, 5A1MQ, 5-amino-1-methylquinolinium salt
$XX.XX
AICAR
Popular Name: Acadesine, AICA-riboside, 5-aminoimidazole-4-carboxamide ribonucleotide
$XX.XX
AOD9604
Popular Name: AOD 9604, AOD-9604, Tyr-hGH 177-191
$XX.XX
CJC-1295 With DAC
Popular Name: CJC-1295 DAC, CJC 1295 with DAC, CJC1295 DAC
$XX.XX
CJC-1295 Without DAC
Popular Name: CJC-1295 no DAC, Mod GRF 1-29, Modified GRF 1-29
$XX.XX
Follistatin
Popular Name: FST, Follistatin 344, FS-344
$XX.XX